Omda Q3 2025 presentation slides: Record 30% EBITDA margin despite acquisition dilution

Omda AS (OMDA) shares climbed 4.54% following its Q3 2025 presentation, which showcased a 14% year-over-year revenue increase and a record 30% EBITDA margin, despite temporary dilution from recent acquisitions. The Norwegian healthcare software provider emphasized 7% organic growth and 15% ARR growth, alongside a strategic "Buy, Integrate, Build" M&A approach designed to integrate acquired businesses to full performance within 12-18 months. Omda provided robust guidance, projecting continued revenue growth to 500-525 million NOK and an improved EBITDA margin of 28-32% by 2026, underpinned by operational efficiencies and sustained M&A activity.

Analysis

Omda AS (OMDA) shares surged 4.54% following a Q3 2025 presentation that showcased robust financial performance, including a 14% year-over-year revenue increase and a record 30% EBITDA margin. This strong operational efficiency, coupled with 7% organic growth and 15% Annual Recurring Revenue (ARR) growth, reflects significant investor confidence and positions the stock near its 52-week high. The company's recurring revenue base, comprising 94% of year-to-date revenue, underscores strong customer retention and stable cash flow generation.

A core component of Omda's strategy is its "Buy, Integrate, Build" (BiB) M&A approach, which temporarily diluted Q3 EBITDA margin by 3 percentage points due to recent acquisitions. Management, however, expressed confidence in integrating these businesses to full performance within 12-18 months, citing a successful track record across 15 prior acquisitions and an extensive pipeline of over 400 potential targets. This strategic M&A is designed to complement organic expansion.

The company provided strong forward guidance, projecting 2026 revenue between 500-525 million NOK and an improved EBITDA margin of 28-32%, indicating expected synergy realization and continued operational leverage. Beyond 2026, Omda targets 10-20% inorganic growth, supported by ongoing personnel expense optimization, COGS reduction, and capital expenditure compression, which are critical drivers for long-term value creation.

Key Decisions for Investors

• Investors should closely monitor the integration success of recent acquisitions, ensuring they contribute to margin expansion as guided within the 12-18 month timeframe
• Evaluate the sustainability of Omda's organic growth and ARR expansion alongside the execution of its ambitious M&A pipeline and operational efficiency targets
• Consider the current valuation of OMDA shares, which are near their 52-week high, against the robust forward guidance and long-term value creation strategy